Abstract 12269: Prognostic Role of Hemoconcentration in Acute Decompensated Heart Failure With Preserved and Reduced Ejection Fraction; an Analysis From Mode of Death

BackgroundsHemoconcentration (HC) during heart failure treatment is known to be associated with improved clinical outcome in patients with acute decompensated heart failure (ADHF). There is a difference in mode of death (cardiac [sudden vs pump failure death] vs non-cardiac death) between heart fail...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A12269-A12269
Main Authors: Yamada, Takahisa, Morita, Takashi, Furukawa, Yoshio, Tamaki, Shunsuke, Iwasaki, Yusuke, Kawasaki, Masato, Kikuchi, Atsushi, Kondo, Takumi, Hakui, Hideyuki, Ishimi, Masashi, Ozaki, Tastsuhisa, Satoh, Yoshihiro, Ikeda, Iyo, Fukuhara, Eiji, Fukunami, Masatake
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundsHemoconcentration (HC) during heart failure treatment is known to be associated with improved clinical outcome in patients with acute decompensated heart failure (ADHF). There is a difference in mode of death (cardiac [sudden vs pump failure death] vs non-cardiac death) between heart failure with preserved (HFpEF) and reduced ejection fraction (HFrEF). However, there is no information available on the different impact of HC in the prediction of mode of death in ADHF patients, relating to HFpEF and HFrEF.Methods and ResultsWe studied 302 patients admitted with ADHF and discharged with survival (HFpEF(LVEF≥50%);n=139, HFrEF(LVEF
ISSN:0009-7322
1524-4539
DOI:10.1161/circ.132.suppl_3.12269